China Animal Healthcare’s delisting from SGX not finalized

The manufacturing company clarifies reports that it may be the subject of a privatisation from SGX and SEHK.

China Animal Healthcare’s statement said, “By way of clarification, the Company wishes to inform shareholders that, as part of its constant evaluation of corporate options which may be beneficial to the Company, the Company is currently contemplating and assessing a potential delisting from the SGX-ST whilst continuing to maintain its primary listing on the SEHK.

The Company would emphasize that:
(a) this announcement is made to clarify speculation which the Company considers could otherwise undesirably affect the orderly trading of the Company's shares to the detriment of its shareholders. The  Company would, given a choice, have preferred to make this announcement only after the Company had  considered and assessed all relevant factors (including consultations with all relevant governmental authorities and regulations) and determined to proceed with a definitive proposal (which it currently has not);

(b) there is NO certainty nor assurance whatsoever that the potential delisting from the SGX-ST will eventually be carried out, as it is still being assessed internally with the assistance of its professional advisers;

(c) the potential delisting from the SGX-ST, if carried out, will be undertaken by the Company as an internal corporate exercise; and

(d) the potential delisting from the SGX-ST, if carried out, is not a privatisation exercise, and the Company's shares will continue to be publicly traded on SEHK.”